Physician profile
Marlene Diaz
NPI 1427166644
$634.85
in general payments reported to CMS, 2019-2025
19 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.46 · 2020: $24.89 · 2021: $24.93 · 2022: $41.33 · 2023: $161 · 2024: $195 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.89 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $138.26 | 2023-2025 | Veozah |
| Millicent US INC | $79.76 | 2023-2024 | Intrarosa, Femring |
| Hologic Sales and Service, LLC | $68.56 | 2023-2025 | Aptima |
| Pfizer INC. | $44.53 | 2024 | |
| Mayne Pharma Commercial LLC | $40.12 | 2024-2025 | |
| Abbvie INC. | $38.74 | 2020-2022 | |
| Exeltis, USA INC. | $28.86 | 2023-2025 | Slynd |
| Avion Pharmaceuticals | $24.26 | 2019-2021 | |
| Novo Nordisk INC | $23.43 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.22 | 2023 | Exparel |
| Ascend Therapeutics US, LLC | $17.93 | 2023 | |
| Aspira Women'S Health INC | $16.38 | 2022 | |
| Organon LLC | $16.08 | 2024 | |
| Acella Pharmaceuticals, LLC | $15.34 | 2024 | NP Thyroid 60 |
| Exact Sciences Corporation | $14.94 | 2025 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $13.64 | 2023 | Twirla |
| Allergan, INC. | $12.72 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.98 | 2021 | |
| Becton, Dickinson and Company | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.